Focus on nonviral vectors for nucleic acid therapeutics: engineering nanoparticles and polymer/peptide carriers for mRNA/DNA, optimizing magnetic and aerosol lung targeting, and characterizing airway biofluid interactions to improve transfection and translation to respiratory therapies.